Neurodegenerative diseases are chronic and still lacking an effective treatment, so they have become a growing concern in our aging society. The lack of therapies adds to the difficulty of studying the effect of new drugs on the brain, because it is not possible to perform a complete diagnosis and pathological study before the death of the patient. The Annals of Neurology published a paper showing that it is possible to monitor the evolution of MS through the retina. Dr. íñigo Gabilondo is the first author of the work, while the last one is Dr. Pablo Villoslada, head of Multiple Sclerosis, Pathogenesis and New Therapies Group at the IDIBAPS’ Neuroimmunology Program. The work was done in collaboration with the Department of Neurology and Ophthalmology at Hospital Clinic of Barcelona, which form the Visual Pathway Laboratory, funded by the Instituto de Salud Carlos III.
Archive for the ‘Hospital Clínic’ Category
IDIBAPS, in addition to working in disease prevention from a research perspective, is actively involved in activities oriented to society. Recently it published a multimedia activity to understand AIDS better, in collaboration with Ambientech and thanks to the Government of Catalonia’s ACDC 2012 funding for science dissemination. Through this interactive activity (in Spanish and Catalan) high school students, and anyone who wishes it, will learn why it is so difficult to combat the HIV virus, how can we prevent it and discuss about how we do approach its carriers.
The Spanish Society of Otolaryngology awards the OLFACAT study as the best clinical work of the year
The Spanish Society of Otorhinolaryngology and Cervicofacial Pathology (SEORL-PCF) has awarded the “Best Clinical Paper published in an international journal” 2013 Award to the OLFACAT study. This work, led by Dr. Joaquim Mullol and his IDIBAPS – Hospital Clínic team Clinical and Experimental Respiratory Immunoallergy, was published in the BMJ Open journal under the title “Furthering the understanding of olfaction, prevalence of loss of smell, and risk factors: a population-based survey (OLFACAT study)“. Dr. Mullol himself is the article first author, while Dr. Concepción Marín is the last one. The award was received by Dr. Mullol during the Congress of the Spanish Society of Otolaryngology held in Madrid from October 25 to 28.
Dr. Elías Campo awarded with the the Premi Nacional de Recerca (Catalan National Award for Research)
Dr. Elías Campo is one of the most prominent researchers at IDIBAPS and Professor of Pathology at the University of Barcelona. He combines the positions of director of research at the Hospital Clínic of Barcelona and director of the Clínic Foundation with his work as head of the IDIBAPS research team Human and experimental functional oncomorphology. Investigations he led as co- director of the Spanish Consortium for the chronic lymphocytic leukemia Genome have provided valuable information on the genetics and treatment of this leukemia, the most common in Western countries. Today has been announced that the Catalan Foundation for Research and Innovation, with support from the Government of Catalonia, has recognized his work with the Premi Nacional de Recerca (Catalan National Award for Research), the highest award of Catalan science. The statement announcing the award highlights that “his research has identified cells that cause leukemia, discovered new molecular mechanisms involved in its development and improved its diagnosis.”
Siemens and Hospital Clínic get minimally invasive techniques to prevent sudden cardiac death, and chronic liver disease
Hospital Clínic of Barcelona today announced results from their collaboration with Siemens Healthcare to use advanced laboratory and imaging technologies for improving patient care management, including early disease detection, diagnosis and monitoring. Since 2008, the collaboration, which is conducted through the Hospital Clínic of Barcelona’s Biomedical Diagnostic Center (CDB), has realized 15 programs across several clinical conditions, including oncology, fetal medicine, gastroenterology, cardiology and liver disease.
A team of researchers from the Center of Regenerative Medicine in Barcelona (CMRB), the Salk Institute in California and the Hospital Clinic – IDIBAPS in Barcelona creates three-dimensional kidney structures in culture using human stem cells. Up to now scientists have had a limited success in producing kidney cells in culture, therefore this new study is a scientific revolution. This progress will facilitate the study of kidney diseases, the discovery of new drugs and is a step forward towards the implementation of stem cell-based therapies.
Information via CMRB